These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15787665)

  • 1. Teaching and motivating patients to control their risk factors retards progression of cardiovascular as well as microvascular sequelae of Type 2 diabetes mellitus- a randomized prospective 8 years follow-up study.
    Rachmani R; Slavachevski I; Berla M; Frommer-Shapira R; Ravid M
    Diabet Med; 2005 Apr; 22(4):410-4. PubMed ID: 15787665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teaching patients to monitor their risk factors retards the progression of vascular complications in high-risk patients with Type 2 diabetes mellitus--a randomized prospective study.
    Rachmani R; Levi Z; Slavachevski I; Avin M; Ravid M
    Diabet Med; 2002 May; 19(5):385-92. PubMed ID: 12027926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of high-risk patients with diabetes: motivation and teaching intervention: a randomized, prospective 8-year follow-up study.
    Rachmani R; Slavacheski I; Berla M; Frommer-Shapira R; Ravid M
    J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S22-6. PubMed ID: 15938028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
    Estacio RO; Jeffers BW; Gifford N; Schrier RW
    Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
    Shichiri M; Kishikawa H; Ohkubo Y; Wake N
    Diabetes Care; 2000 Apr; 23 Suppl 2():B21-9. PubMed ID: 10860187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factors predictive of cardiovascular disease in patients with type-2 diabetes and hypercholesterolemia. ESODIAH study].
    Pintó X; Corbella E; Figueras R; Biarnés J; Ricart W; Morales C; Falkon L; Masana L;
    Rev Esp Cardiol; 2007 Mar; 60(3):251-8. PubMed ID: 17394870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno-2 study].
    Gaede PH; Jepsen PV; Parving HH; Pedersen OB
    Ugeskr Laeger; 1999 Jul; 161(30):4277-85. PubMed ID: 10439688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors of diabetic nephropathy progression in patients with a long history of diabetic mellitus as shown by a retrospective analysis].
    Shestakova MV; Koshel' LV; Vagodin VA; Dedov II
    Ter Arkh; 2006; 78(5):60-4. PubMed ID: 16889052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of macrovascular diseases is reduced in type 1 diabetic patients after more than 5 years successful combined pancreas-kidney transplantation in comparison to kidney transplantation alone.
    Biesenbach G; Königsrainer A; Gross C; Margreiter R
    Transpl Int; 2005 Sep; 18(9):1054-60. PubMed ID: 16101726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study.
    Romero P; Baget M; Mendez I; Fernández J; Salvat M; Martinez I
    J Diabetes Complications; 2007; 21(3):172-80. PubMed ID: 17493551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients.
    Cardoso CR; Salles GF
    J Diabetes Complications; 2008; 22(3):164-70. PubMed ID: 18413219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinic.
    Al-Wakeel JS; Hammad D; Al Suwaida A; Mitwalli AH; Memon NA; Sulimani F
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):77-85. PubMed ID: 19112222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
    Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of structured hospital-based care compared with standard care for Type 2 diabetes-The Asker and Baerum Cardiovascular Diabetes Study, a randomized trial.
    Johansen OE; Gullestad L; Blaasaas KG; Orvik E; Birkeland KI
    Diabet Med; 2007 Sep; 24(9):1019-27. PubMed ID: 17509068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quality of diabetes education and shared care between family practice and the diabetes clinic].
    Sadauskiene L; Jørgensen UL; Pedersen J; Møller CC; Grodum E; Gjessing HJ
    Ugeskr Laeger; 2008 May; 170(21):1805-8. PubMed ID: 18492445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients.
    Targher G; Bertolini L; Zenari L; Lippi G; Pichiri I; Zoppini G; Muggeo M; Arcaro G
    Diabet Med; 2008 Jan; 25(1):45-50. PubMed ID: 18199131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4).
    Martin S; Schramm W; Schneider B; Neeser K; Weber C; Lodwig V; Heinemann L; Scherbaum WA; Kolb H
    Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):495-501. PubMed ID: 17853332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
    Dussol B; Berland Y
    Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.